Virginia STEM News
SEE OTHER BRANDS

Daily news on science and technology in Virginia

Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on October 6, 2025

Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
Jacaranda Health remporte le Prix Rotman de l’innovation de l’année 2025 de Grands Défis Canada
Jacaranda Health Wins Grand Challenges Canada’s 2025 Rotman Innovation of the Year Award
Equillium Announces Leadership and Corporate Updates
Veeco Launches Lumina+ MOCVD System, Receives Multi Tool Order for High-Volume Production of Compound Semiconductor Products
Reemo Unveils Bastion+: A Scalable Solution for Global Privileged Access Management
CORRECTION -- Innventure announces strategic investment in Accelsius by Johnson Controls
Theriva™ Biologics anuncia la presentación del VCN-12, un adenovirus oncolítico de nueva generación, en el 32.º Congreso Anual de la Sociedad Europea de Terapia Génica y Celular (ESGCT)
Scrum Alliance and Coursera Bring Agile Skills to Learners Worldwide
Rolyca Exchange Announces System Upgrade to Enhance Global Trading Performance
Hechosa Exchange Launches Global Platform Connecting Fine Art and Digital Assets
gCurv Launches First AI-Powered Platform “Packgine” to Automate Global Packaging Compliance and ESG Reporting
BPGbio Appoints Veteran Clinical and Commercial Leader Dr. Brian Berman as Interim Chief Medical Officer
Pharming Group provides update on previously announced G&A expense reduction plan
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
Valneva consolide sa position de trésorerie en refinançant sa dette auprès de Pharmakon Advisors et fait un point sur ses activités
US Rheumatologists View Cell Therapy as a Potential Game Changer, with Systemic Sclerosis Emerging as the Most Compelling Indication, According to Spherix Global Insights
Planful Announces John Herr as Chief Executive Officer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions